299 related articles for article (PubMed ID: 32819111)
1. A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base.
Martinez NL; Khanna O; Farrell CJ
Chin Clin Oncol; 2020 Dec; 9(6):75. PubMed ID: 32819111
[TBL] [Abstract][Full Text] [Related]
2. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
[TBL] [Abstract][Full Text] [Related]
3. Nonmalignant Brain Tumors.
Lukas RV; Mrugala MM
Continuum (Minneap Minn); 2020 Dec; 26(6):1495-1522. PubMed ID: 33273170
[TBL] [Abstract][Full Text] [Related]
4. Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas.
Peyre M; Feuvret L; Sanson M; Navarro S; Boch AL; Loiseau H; Kalamarides M
J Neurooncol; 2017 Jul; 133(3):633-639. PubMed ID: 28536991
[TBL] [Abstract][Full Text] [Related]
5. Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model.
Iwami K; Natsume A; Ohno M; Ikeda H; Mineno J; Nukaya I; Okamoto S; Fujiwara H; Yasukawa M; Shiku H; Wakabayashi T
Neuro Oncol; 2013 Jun; 15(6):747-58. PubMed ID: 23460320
[TBL] [Abstract][Full Text] [Related]
6. Current treatment options for meningioma.
Apra C; Peyre M; Kalamarides M
Expert Rev Neurother; 2018 Mar; 18(3):241-249. PubMed ID: 29338455
[TBL] [Abstract][Full Text] [Related]
7. Skull Base Tumors.
Forst DA; Jones PS
Continuum (Minneap Minn); 2023 Dec; 29(6):1752-1778. PubMed ID: 38085897
[TBL] [Abstract][Full Text] [Related]
8. Craniopharyngioma in Pediatrics and Adults.
Piloni M; Gagliardi F; Bailo M; Losa M; Boari N; Spina A; Mortini P
Adv Exp Med Biol; 2023; 1405():299-329. PubMed ID: 37452943
[TBL] [Abstract][Full Text] [Related]
9. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C
Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067
[TBL] [Abstract][Full Text] [Related]
10. Anterior Skull Base Tumor Resection by Transciliary Supraorbital Keyhole Craniotomy: A Single Institutional Experience.
Lin YJ; Chen KT; Lee CC; Toh CH; Wu TE; Huang YC; Hsu PW; Lu YJ; Chuang CC; Chen PY; Wei KC
World Neurosurg; 2018 Mar; 111():e863-e870. PubMed ID: 29325954
[TBL] [Abstract][Full Text] [Related]
11. [Surgery of the base of the skull].
Konovalov AN; Makhmudov UB; Kadashev BA; Cherekaev VA; Taniashin SV; Shimanskiĭ VN; Trunin IuK; Mukhametzhanov DZh; Spallone A; Shkarubo AN; Ivanov SL; Usachev DIu; Vinokurov AG
Zh Vopr Neirokhir Im N N Burdenko; 1998; (4):3-9. PubMed ID: 9988884
[TBL] [Abstract][Full Text] [Related]
12. High-grade meningiomas: biology and implications.
Bi WL; Prabhu VC; Dunn IF
Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053
[TBL] [Abstract][Full Text] [Related]
13. Craniopharyngioma: a roadmap for scientific translation.
Gupta S; Bi WL; Giantini Larsen A; Al-Abdulmohsen S; Abedalthagafi M; Dunn IF
Neurosurg Focus; 2018 Jun; 44(6):E12. PubMed ID: 29852761
[TBL] [Abstract][Full Text] [Related]
14. New prospects for management and treatment of inoperable and recurrent skull base meningiomas.
Johnson MD; Sade B; Milano MT; Lee JH; Toms SA
J Neurooncol; 2008 Jan; 86(1):109-22. PubMed ID: 17624496
[TBL] [Abstract][Full Text] [Related]
15. Skull Base Tumors: Neuropathology and Clinical Implications.
Bi WL; Santagata S
Neurosurgery; 2022 Mar; 90(3):243-261. PubMed ID: 34164689
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms.
Pham MH; Zada G; Mosich GM; Chen TC; Giannotta SL; Wang K; Mack WJ
Neurosurg Focus; 2011 May; 30(5):E7. PubMed ID: 21529178
[TBL] [Abstract][Full Text] [Related]
17. Co-localisation of meningioma and craniopharyngioma mimicking a single skull base tumour in an elderly patient.
Della Puppa A; Del Moro G; Tosatto L; Manara R; Orvieto E; Gardiman MP; Scienza R
J Neurooncol; 2011 Mar; 102(1):167-70. PubMed ID: 20617364
[TBL] [Abstract][Full Text] [Related]
18. Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas.
Strickland MR; Gill CM; Nayyar N; D'Andrea MR; Thiede C; Juratli TA; Schackert G; Borger DR; Santagata S; Frosch MP; Cahill DP; Brastianos PK; Barker FG
J Neurosurg; 2017 Aug; 127(2):438-444. PubMed ID: 27885953
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
Abedalthagafi M; Bi WL; Aizer AA; Merrill PH; Brewster R; Agarwalla PK; Listewnik ML; Dias-Santagata D; Thorner AR; Van Hummelen P; Brastianos PK; Reardon DA; Wen PY; Al-Mefty O; Ramkissoon SH; Folkerth RD; Ligon KL; Ligon AH; Alexander BM; Dunn IF; Beroukhim R; Santagata S
Neuro Oncol; 2016 May; 18(5):649-55. PubMed ID: 26826201
[TBL] [Abstract][Full Text] [Related]
20. [Endoscopic endonasal surgery for extrasellar tumors: case presentation and its future perspective].
Saeki N; Murai H; Hasegawa Y; Horiguchi K; Hanazawa T; Fukuda K
No Shinkei Geka; 2009 Mar; 37(3):229-46. PubMed ID: 19306643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
